-
5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICA-riboside) as a targeting agent for therapy of patients with acute lymphoblastic leukemia: are we there and are there pitfalls?
NYU School of Medicine, New York, New York, USA.
PMID: 18090925 [PubMed - indexed for MEDLINE]
-